Angiotensin-(1–7) prevents systemic hypertension, attenuates oxidative stress and tubulointerstitial fibrosis, and normalizes renal angiotensin-converting enzyme 2 and Mas receptor expression in diabetic mice

Heterogeneous nuclear ribonucleoproteins F and K mediate insulin inhibition of renal angiotensinogen gene expression and prevention of hypertension and kidney injury in diabetic mice

(2013) S. Abdo et al.   DIABETOLOGIA

NADPH Oxidases, Reactive Oxygen Species, and the Kidney: Friend and Foe

(2013) M. Sedeek et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Heterogeneous Nuclear Ribonucleoprotein F Suppresses Angiotensinogen Gene Expression and Attenuates Hypertension and Kidney Injury in Diabetic Mice

(2012) C.-S. Lo et al.   DIABETES

Angiotensin II Type II Receptor Deficiency Accelerates the Development of Nephropathy in Type I Diabetes via Oxidative Stress and ACE2

(2011) Shiao-Ying Chang et al.   Experimental Diabetes Research

Regulation of angiotensin-converting enzyme 2 and Mas receptor by Ang-(1–7) in heart and kidney of spontaneously hypertensive rats

(2011) Zhen Tan et al.   JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM

Angiotensin-converting enzyme 2: enhancing the degradation of angiotensin II as a potential therapy for diabetic nephropathy

(2011) Daniel Batlle et al.   KIDNEY INTERNATIONAL

Angiotensin-(1–7) prevents diabetes-induced attenuation in PPAR-γ and catalase activities

(2010) Gursev S. Dhaunsi et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Prevention of Angiotensin II–Mediated Renal Oxidative Stress, Inflammation, and Fibrosis by Angiotensin-Converting Enzyme 2

(2010) JiuChang Zhong et al.   HYPERTENSION

Catalase overexpression prevents hypertension and tubular apoptosis in angiotensinogen transgenic mice

(2010) Nicolas Godin et al.   KIDNEY INTERNATIONAL

The NADPH Oxidase Subunit NOX4 Is a New Target Gene of the Hypoxia-inducible Factor-1

(2010) Isabel Diebold et al.   MOLECULAR BIOLOGY OF THE CELL

Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy

(2009) G. Y. Oudit et al.   DIABETES

Targeting the Degradation of Angiotensin II With Recombinant Angiotensin-Converting Enzyme 2

(2009) Jan Wysocki et al.   HYPERTENSION

Reduction of Renal Superoxide Dismutase in Progressive Diabetic Nephropathy

(2009) H. Fujita et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Expression of ACE and ACE2 in Individuals With Diabetic Kidney Disease and Healthy Controls

(2008) Sonoo Mizuiri et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Angiotensin II Up-Regulates Angiotensin I-Converting Enzyme (ACE), but Down-Regulates ACE2 via the AT1-ERK/p38 MAP Kinase Pathway

(2008) Vijay Koka et al.   AMERICAN JOURNAL OF PATHOLOGY

Angiotensin-converting enzyme 2: implications for blood pressure and kidney disease

(2008) Julie R Ingelfinger   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease

(2008) Heather N. Reich et al.   KIDNEY INTERNATIONAL

Apocynin attenuates tubular apoptosis and tubulointerstitial fibrosis in transgenic mice independent of hypertension

(2008) Fang Liu et al.   KIDNEY INTERNATIONAL

Nrf2 as a Master Redox Switch in Turning on the Cellular Signaling Involved in the Induction of Cytoprotective Genes by Some Chemopreventive Phytochemicals

(2008) Young-Joon Surh et al.   PLANTA MEDICA

Overexpression of Angiotensinogen Increases Tubular Apoptosis in Diabetes

(2007) F. Liu et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY